BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 18163472)

  • 1. CyTOF Intracellular Cytokine Assays for Antigen-Specific T Cells.
    Lin D; Maecker HT
    Methods Mol Biol; 2024; 2779():395-405. PubMed ID: 38526796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulation.
    Vaitaitis G; Webb T; Webb C; Sharkey C; Sharkey S; Waid D; Wagner DH
    Front Immunol; 2023; 14():1319947. PubMed ID: 38318506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).
    Curran C; Vaitaitis G; Waid D; Volmer T; Alverez E; Wagner DH
    J Neuroimmunol; 2023 Jan; 374():578008. PubMed ID: 36535240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment.
    Gonzalez VD; Huang YW; Delgado-Gonzalez A; Chen SY; Donoso K; Sachs K; Gentles AJ; Allard GM; Kolahi KS; Howitt BE; Porpiglia E; Fantl WJ
    Cell Rep; 2021 Aug; 36(9):109632. PubMed ID: 34469729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
    Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
    Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.
    Lyu C; Bing SJ; Wandu WS; Xu B; Shi G; Hinshaw SJ; Lobera M; Caspi RR; Lu L; Yang J; Gery I
    Eur J Immunol; 2018 Nov; 48(11):1810-1816. PubMed ID: 30218573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.
    Wagner DH
    Front Endocrinol (Lausanne); 2017; 8():208. PubMed ID: 28878738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-mediated signalling influences trafficking, T-cell receptor expression, and T-cell pathogenesis, in the NOD model of type 1 diabetes.
    Vaitaitis GM; Waid DM; Yussman MG; Wagner DH
    Immunology; 2017 Oct; 152(2):243-254. PubMed ID: 28542921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal Degeneration.
    Hinshaw SJ; Ogbeifun O; Wandu WS; Lyu C; Shi G; Li Y; Qian H; Gery I
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1441-7. PubMed ID: 27028065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.
    Deng G; Carter J; Traystman RJ; Wagner DH; Herson PS
    J Neuroimmunol; 2014 Sep; 274(1-2):132-40. PubMed ID: 25084739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
    Waid DM; Schreiner T; Vaitaitis G; Carter JR; Corboy JR; Wagner DH
    J Neuroimmunol; 2014 May; 270(1-2):75-85. PubMed ID: 24690203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput sequencing of islet-infiltrating memory CD4+ T cells reveals a similar pattern of TCR Vβ usage in prediabetic and diabetic NOD mice.
    Marrero I; Hamm DE; Davies JD
    PLoS One; 2013; 8(10):e76546. PubMed ID: 24146886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.
    Vaitaitis GM; Carter JR; Waid DM; Olmstead MH; Wagner DH
    J Immunol; 2013 Jul; 191(2):717-25. PubMed ID: 23776180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27.
    Hedrich CM; Ramakrishnan A; Dabitao D; Wang F; Ranatunga D; Bream JH
    Mol Immunol; 2010; 48(1-3):73-81. PubMed ID: 20952070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-specific regulation of IL-10 expression in inflammation and disease.
    Hedrich CM; Bream JH
    Immunol Res; 2010 Jul; 47(1-3):185-206. PubMed ID: 20087682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interleukin-12 in the heavy metal-elicited immunomodulation: relevance of various evaluation methods.
    Hemdan NY
    J Occup Med Toxicol; 2008 Nov; 3():25. PubMed ID: 18990205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analytical workflow for investigating cytokine profiles.
    Siebert JC; Inokuma M; Waid DM; Pennock ND; Vaitaitis GM; Disis ML; Dunne JF; Wagner DH; Maecker HT
    Cytometry A; 2008 Apr; 73(4):289-98. PubMed ID: 18163472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric evaluation of intracellular cytokine synthesis in peripheral mononuclear cells of women with endometriosis.
    Gmyrek GB; Sieradzka U; Goluda M; Gabrys M; Sozanski R; Jerzak M; Zbyryt I; Chrobak A; Chełmonska-Soyta A
    Immunol Invest; 2008; 37(1):43-61. PubMed ID: 18214799
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.